Skip to main content
Medic Debate
- The Antidote to Medical Misinformation and Propaganda!
Languages
Dansk
Nederlands
English
Français
Deutsch
Italiano
Español
Kiswahili
Svenska
Search form
Search
Main menu
Home
Search
About us
Books
Category Search
Log In
Recent posts
Treatment Protocols
You are here
Home
Phase III Clinical Trial
Items per page
5
10
20
40
60
100
Title
Average Rating
Regional hyperthermia (RHT) improves response and survival when combined with systemic chemotherapy in the management of local..
80.00%
Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative....
Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative..
80.00%
Prostate specific antigen bounce after simultaneous irradiation for prostate cancer: the relationship to patient age.
Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer.
50.00%
Oxytrex minimizes physical dependence while providing effective analgesia: a randomized controlled trial in low back pain.
80.00%
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer
50.00%
Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor acti
90.00%
Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal ca. patients
70.00%
Effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer.
50.00%
Continuous versus intermittent tamoxifen versus intermittent/alternated tamoxifen and medroxyprogesterone acetate as first line
50.00%
Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer
50.00%
Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal
50.00%
A phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small cell..
50.00%
SWOG 0012, a randomized phase III comparison of standard doxorubicin (A) and cyclophosphamide (C) followed by weekly paclitaxel
60.00%
Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplat
40.00%
Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-indep..
70.00%